-
Wolters, PL, Martin, S, Merker, VL, Tonsgard, JH, Solomon, SE, Baldwin, A, Bergner, AL, Walsh, K, Thompson, HL, Gardner, KL, et al. Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.
Neurology
87(7_Supplement_1)
:
s4 -s12
2016
view publication
-
Hanemann, CO, Blakeley, JO, Nunes, FP, Robertson, K, Stemmer-Rachamimov, A, Mautner, V, Kurtz, A, Ferguson, M, Widemann, BC, Evans, DG, et al. Current status and recommendations for biomarkers and biobanking in neurofibromatosis.
Neurology
87(7_Supplement_1)
:
s40 -s48
2016
view publication
-
Yuen, M, Sandaradura, SA, Dowling, JJ, Kostyukova, AS, Moroz, N, Quinlan, KG, Lehtokari, V-L, Ravenscroft, G, Todd, EJ, Ceyhan-Birsoy, O, et al. Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy.
Journal of Clinical Investigation
125(1)
:
456 -457
2015
view publication
-
Redpath, G, Woolger, N, Piper, A, Lemckert, F, Lek, A, Greer, P, North, K, Cooper, S. Calpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair.
Molecular Biology of the Cell
25(19)
:
mbc.e14-04-0947
2014
view publication
-
Bushby, K, Finkel, R, Wong, B, Barohn, R, Campbell, C, Comi, GP, Connolly, AM, Day, JW, Flanigan, KM, Goemans, N, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy.
Muscle & Nerve
50(4)
:
477 -487
2014
view publication